References
- Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the sustainable development goals. Lancet. 2016;388(10063):1–11. doi: 10.1016/S0140-6736(16)31593-8.
- Chawanpaiboon S, Vogel JP, Moller A-B, et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob Health. 2019;7(1):e37–e46. doi: 10.1016/S2214-109X(18)30451-0.
- World Health Organization. Preterm birth fact sheet. WHO; 2023. https://www.who.int/news-room/fact-sheets/detail/preterm-birth.
- Perin J, Mulick A, Yeung D, et al. Global, regional, and national causes of under-5 mortality in 2000-19: an updated systematic analysis with implications for the sustainable development goals. Lancet Child Adolesc Health. 2022;6(2):106–115. doi: 10.1016/S2352-4642(21)00311-4.
- Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75–84. doi: 10.1016/S0140-6736(08)60074-4.
- Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol. 2003;101(1):178–193. doi: 10.1016/s0029-7844(02)02366-9.
- Watts DH, Krohn MA, Hillier SL, et al. The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet Gynecol. 1992;79(3):351–357. doi: 10.1097/00006250-199203000-00005.
- Venkatesh KK, Leviton A, Hecht JL, et al. Histologic chorioamnionitis and risk of neurodevelopmental impairment at age 10 years among extremely preterm infants born before 28 weeks of gestation. Am J Obstet Gynecol. 2020;223(5):745.e1–745.e10. doi: 10.1016/j.ajog.2020.05.001.
- McDowell KM, Jobe AH, Fenchel M, et al. Pulmonary morbidity in infancy after exposure to chorioamnionitis in late preterm infants. Ann Am Thorac Soc. 2016;13(6):867–876. doi: 10.1513/AnnalsATS.201507-411OC.
- Viscardi RM. Perinatal inflammation and lung injury. Semin Fetal Neonatal Med. 2012;17(1):30–35. doi: 10.1016/j.siny.2011.08.002.
- Villamor-Martinez E, Álvarez-Fuente M, Ghazi AMT, et al. Association of chorioamnionitis with bronchopulmonary dysplasia among preterm infants: a systematic review, meta-analysis, and metaregression. JAMA Netw Open. 2019;2(11):e1914611. doi: 10.1001/jamanetworkopen.2019.14611.
- Been JV, Lievense S, Zimmermann LJI, et al. Chorioamnionitis as a risk factor for necrotizing enterocolitis: a systematic review and meta-analysis. J Pediatr. 2013;162(2):236.e2–242.e2. doi: 10.1016/j.jpeds.2012.07.012.
- Wu YW, Colford JMJr. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA. 2000;284(11):1417–1424. doi: 10.1001/jama.284.11.1417.
- Crump C, Sundquist J, Sundquist K. Preterm or early term birth and risk of autism. Pediatrics. 2021;148(3):1–21. doi: 10.1542/peds.2020-032300.
- Tsamantioti E, Lisonkova S, Muraca G, et al. Chorioamnionitis and risk of long-term neurodevelopmental disorders in offspring: a population-based cohort study. Am J Obstet Gynecol. 2022;227(2):287.e1–287.e17. doi: 10.1016/j.ajog.2022.03.028.
- Duley L, Uhm S, Oliver S. Top 15 UK research priorities for preterm birth. Lancet. 2014;383(9934):2041–2042. doi: 10.1016/S0140-6736(14)60989-2.
- Grigsby PL, Novy MJ, Sadowsky DW, et al. Maternal azithromycin therapy for ureaplasma intraamniotic infection delays preterm delivery and reduces fetal lung injury in a primate model. Am J Obstet Gynecol. 2012;207(6):475.e1–475.e14. doi: 10.1016/j.ajog.2012.10.871.
- Toth A, Steinmeyer S, Kannan P, et al. Inflammatory blockade prevents injury to the developing pulmonary gas exchange surface in preterm primates. Sci Transl Med. 2022;14(638):eabl8574. doi: 10.1126/scitranslmed.abl8574.
- Lee J, Romero R, Kim SM, et al. A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM. J Matern Fetal Neonatal Med. 2016;29(5):707–720. doi: 10.3109/14767058.2015.1020293.
- Kelleher MA, Lee JY, Roberts VHJ, et al. Maternal azithromycin therapy for Ureaplasma parvum intraamniotic infection improves fetal hemodynamics in a nonhuman primate model. Am J Obstet Gynecol. 2020;223(4):578.e1–578.e11. doi: 10.1016/j.ajog.2020.04.015.
- Cappelletti M, Presicce P, Feiyang M, et al. The induction of preterm labor in rhesus macaques is determined by the strength of immune response to intrauterine infection. PLoS Biol. 2021;19(9):e3001385. doi: 10.1371/journal.pbio.3001385.
- Singh N, Bonney E, McElrath T, et al. Prevention of preterm birth: proactive and reactive clinical practice-are we on the right track? Placenta. 2020;98:6–12. doi: 10.1016/j.placenta.2020.07.021.
- Hodor JG, Poggi SH, Spong CY, et al. Risk of third-trimester amniocentesis: a case-control study. Am J Perinatol. 2006;23(3):177–180. doi: 10.1055/s-2006-934100.
- Navaratnam K,AZ. The Royal College of Obstetricians and Gynaecologists, amniocentesis and chorionic villus sampling: green top guideline number 8. British Journal of Obstetrics and Gynaecology. 2022;1(129):15.
- McIntosh JJ, McHugh K, Haas DM. Difficulties in establishing routine amniocentesis for preterm labor evaluation. J Matern Fetal Neonatal Med. 2012;25(3):313–314. doi: 10.3109/14767058.2011.573826.
- Thomson AJ. Care of women presenting with suspected preterm prelabour rupture of membranes from 24(+0) weeks of gestation: green-top guideline no. 73. BJOG. 2019;126(9):e152–e166. doi: 10.1111/1471-0528.15803.
- Prelabor rupture of membranes: ACOG practice bulletin, number 217. Obstet Gynecol. 2020;135(3):e80–e97.
- Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. doi: 10.1136/bmj.n71.
- Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi: 10.1136/bmj.l4898.
- Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. doi: 10.1136/bmj.i4919.
- Ovalle A, Martínez MA, Kakarieka E, et al. Antibiotic administration in patients with preterm premature rupture of membranes reduces the rate of histological chorioamnionitis: a prospective, randomized, controlled study. J Matern Fetal Neonatal Med. 2002;12(1):35–41. doi: 10.1080/713605581.
- Angus SR, Segel SY, Hsu CD, et al. Amniotic fluid matrix metalloproteinase-8 indicates intra-amniotic infection. Am J Obstet Gynecol. 2001;185(5):1232–1238. doi: 10.1067/mob.2001.118654.
- Cobo T, Aldecoa V, Figueras F, et al. Development and validation of a multivariable prediction model of spontaneous preterm delivery and microbial invasion of the amniotic cavity in women with preterm labor. Am J Obstet Gynecol. 2020;223(3):421.e1–421.e14. doi: 10.1016/j.ajog.2020.02.049.
- Combs CA, Gravett M, Garite TJ, et al. Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes. Am J Obstet Gynecol. 2014;210(2):125.e1–125.e15. doi: 10.1016/j.ajog.2013.11.032.
- Ferrazzi E, Muggiasca ML, Fabbri E, et al. Assessment of fetal inflammatory syndrome by “classical” markers in the management of preterm labor: a possible lesson from metabolomics and system biology. J Matern Fetal Neonatal Med. 2012;25(sup5):54–61. doi: 10.3109/14767058.2012.716984.
- Jacobsson B, Mattsby-Baltzer I, Andersch B, et al. Microbial invasion and cytokine response in amniotic fluid in a Swedish population of women with preterm prelabor rupture of membranes. Acta Obstet Gynecol Scand. 2003;82(5):423–431. doi: 10.1034/j.1600-0412.2003.00157.x.
- Leaños-Miranda A, Nolasco-Leaños AG, Carrillo-Juárez RI, et al. Interleukin-6 in amniotic fluid: a reliable marker for adverse outcomes in women in preterm labor and intact membranes. Fetal Diagn Ther. 2021;48(4):313–320. doi: 10.1159/000514898.
- Kacerovsky M, Romero R, Stepan M, et al. Antibiotic administration reduces the rate of intraamniotic inflammation in preterm prelabor rupture of the membranes. Am J Obstet Gynecol. 2020;223(1):114.e1–114.e20. doi: 10.1016/j.ajog.2020.01.043.
- Kacerovsky M, Pliskova L, Bolehovska R, et al. The impact of the microbial load of genital mycoplasmas and gestational age on the intensity of intraamniotic inflammation. Am J Obstet Gynecol. 2012;206(4):342.e1–342.e8. doi: 10.1016/j.ajog.2012.01.004.
- Kacerovsky M, Pliskova L, Bolehovska R, et al. Lactobacilli-dominated cervical microbiota in women with preterm prelabor rupture of membranes. Pediatr Res. 2020;87(5):952–960. doi: 10.1038/s41390-019-0692-1.
- Musilova I, Andrys C, Krejsek J, et al. Amniotic fluid pentraxins: potential early markers for identifying intra-amniotic inflammatory complications in preterm pre-labor rupture of membranes. Am J Reprod Immunol. 2018;79(5):e12789.
- Musilova I, Spacek R, Stranik J, et al. Fetal portal system flowmetry and intra-amniotic inflammation in preterm prelabor rupture of membranes. Fetal Diagn Ther. 2019;46(5):323–332. doi: 10.1159/000496203.
- Musilova I, Pliskova L, Gerychova R, et al. Maternal white blood cell count cannot identify the presence of microbial invasion of the amniotic cavity or intra-amnioticinflammation in women with pretermprelabor rupture of membranes. PLoS One. 2017;12(12):e0189394. doi: 10.1371/journal.pone.0189394.
- Musilova I, Bestvina T, Stranik J, et al. Transabdominal amniocentesis is a feasible and safe procedure in preterm prelabor rupture of membranes. Fetal Diagn Ther. 2017;42(4):257–261. doi: 10.1159/000457951.
- Fulova V, Studnickova HE, Huml M, et al. Transabdominal amniocentesis in expectant management of preterm premature rupture of membranes: a single center prospective study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021;165(3):305–315. doi: 10.5507/bp.2020.041.
- Spencer RN, Hecher K, Norman G, et al. Development of standard definitions and grading for maternal and fetal adverse event terminology. Prenat Diagn. 2022;42(1):15–26. doi: 10.1002/pd.6047.